Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.

Gupta S, Greenberg S, Grimmett J, Gaston D, Agarwal N, Lowrance W, Schiffman J, Kohlmann W.

Fam Cancer. 2017 Mar 18. doi: 10.1007/s10689-017-9980-2. [Epub ahead of print]

PMID:
28315974
2.

Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.

Carmichael H, Matsen C, Freer P, Kohlmann W, Stein M, Buys SS, Colonna S.

Breast Cancer Res Treat. 2017 Apr;162(2):225-230. doi: 10.1007/s10549-017-4122-y. Epub 2017 Jan 30. Review.

PMID:
28138892
3.

Reply to P.R. Benusiglio et al.

Kinney AY, Kohlmann W, Brumbach BH, Schwartz MD.

J Clin Oncol. 2017 Jan 23:JCO2016709303. doi: 10.1200/JCO.2016.70.9303. [Epub ahead of print] No abstract available.

PMID:
28113008
4.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, Offit K, Pal T, Reiser G, Shannon KM, Swisher E, Vinayak S, Voian NC, Weitzel JN, Wick MJ, Wiesner GL, Dwyer M, Darlow S.

J Natl Compr Canc Netw. 2017 Jan;15(1):9-20.

PMID:
28040716
5.

Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.

Johns D, Agarwal J, Anderson L, Ying J, Kohlmann W.

J Womens Health (Larchmt). 2016 Dec 6. [Epub ahead of print]

PMID:
27922795
6.

Discussing and managing hematologic germ line variants.

Kohlmann W, Schiffman JD.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):309-315.

PMID:
27913496
7.

Development of an Educational Program Integrating Concepts of Genetic Risk and Preventive Strategies for Children with a Family History of Melanoma.

Wu YP, Aspinwall LG, Nagelhout E, Kohlmann W, Kaphingst KA, Homburger S, Perkins RD, Grossman D, Harding G, Cassidy P, Leachman SA.

J Cancer Educ. 2016 Nov 26. [Epub ahead of print]

PMID:
27889875
8.

Discussing and managing hematologic germ line variants.

Kohlmann W, Schiffman JD.

Blood. 2016 Nov 24;128(21):2497-2503. Review.

PMID:
27881370
9.

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.

Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H, Gallinger B, Naumer A, Kohlmann W, Novokmet A, Tabori U, Tijerin M, Greer ML, Finlay JL, Schiffman JD, Malkin D.

Lancet Oncol. 2016 Sep;17(9):1295-305. doi: 10.1016/S1470-2045(16)30249-2. Epub 2016 Aug 5.

10.

Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families.

Flores KG, Steffen LE, McLouth CJ, Vicuña BE, Gammon A, Kohlmann W, Vigil L, Dayao ZR, Royce ME, Kinney AY.

J Genet Couns. 2016 Aug 6. [Epub ahead of print]

PMID:
27496122
11.

Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.

Kinney AY, Steffen LE, Brumbach BH, Kohlmann W, Du R, Lee JH, Gammon A, Butler K, Buys SS, Stroup AM, Campo RA, Flores KG, Mandelblatt JS, Schwartz MD.

J Clin Oncol. 2016 Aug 20;34(24):2914-24. doi: 10.1200/JCO.2015.65.9557. Epub 2016 Jun 20.

PMID:
27325848
12.

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S.

J Natl Compr Canc Netw. 2016 Feb;14(2):153-62.

PMID:
26850485
13.

Multigene testing of moderate-risk genes: be mindful of the missense.

Young EL, Feng BJ, Stark AW, Damiola F, Durand G, Forey N, Francy TC, Gammon A, Kohlmann WK, Kaphingst KA, McKay-Chopin S, Nguyen-Dumont T, Oliver J, Paquette AM, Pertesi M, Robinot N, Rosenthal JS, Vallee M, Voegele C, Hopper JL, Southey MC, Andrulis IL, John EM, Hashibe M, Gertz J; Breast Cancer Family Registry., Le Calvez-Kelm F, Lesueur F, Goldgar DE, Tavtigian SV.

J Med Genet. 2016 Jun;53(6):366-76. doi: 10.1136/jmedgenet-2015-103398. Epub 2016 Jan 19.

14.

Economic Evaluation Alongside a Clinical Trial of Telephone Versus In-Person Genetic Counseling for BRCA1/2 Mutations in Geographically Underserved Areas.

Chang Y, Near AM, Butler KM, Hoeffken A, Edwards SL, Stroup AM, Kohlmann W, Gammon A, Buys SS, Schwartz MD, Peshkin BN, Kinney AY, Mandelblatt JS, Chang Y, Near AM, Butler KM, Hoeffken A, Edwards SL, Stroup AM, Kohlmann W, Gammon A, Buys SS, Schwartz MD, Peshkin BN, Kinney AY, Mandelblatt JS.

J Oncol Pract. 2016 Jan;12(1):59, e1-13. doi: 10.1200/JOP.2015.004838.

15.

Effectiveness of the extended parallel process model in promoting colorectal cancer screening.

Birmingham WC, Hung M, Boonyasiriwat W, Kohlmann W, Walters ST, Burt RW, Stroup AM, Edwards SL, Schwartz MD, Lowery JT, Hill DA, Wiggins CL, Higginbotham JC, Tang P, Hon SD, Franklin JD, Vernon S, Kinney AY.

Psychooncology. 2015 Jul 20. doi: 10.1002/pon.3899. [Epub ahead of print]

PMID:
26194469
16.

Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone.

Taber JM, Aspinwall LG, Stump TK, Kohlmann W, Champine M, Leachman SA.

J Behav Med. 2015 Oct;38(5):740-53. doi: 10.1007/s10865-015-9648-z. Epub 2015 Jul 16.

17.

Efficacy of a Telehealth Intervention on Colonoscopy Uptake When Cost Is a Barrier: The Family CARE Cluster Randomized Controlled Trial.

Steffen LE, Boucher KM, Damron BH, Pappas LM, Walters ST, Flores KG, Boonyasiriwat W, Vernon SW, Stroup AM, Schwartz MD, Edwards SL, Kohlmann WK, Lowery JT, Wiggins CL, Hill DA, Higginbotham JC, Burt R, Simmons RG, Kinney AY.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1311-8. doi: 10.1158/1055-9965.EPI-15-0150. Epub 2015 Jun 22.

18.

Discussion of photoprotection, screening, and risk behaviors with children and grandchildren after melanoma genetic testing.

Wu YP, Aspinwall LG, Michaelis TC, Stump T, Kohlmann WG, Leachman SA.

J Community Genet. 2016 Jan;7(1):21-31. doi: 10.1007/s12687-015-0243-3. Epub 2015 Jun 23.

19.

Impact of melanoma genetic test reporting on perceived control over melanoma prevention.

Aspinwall LG, Stump TK, Taber JM, Kohlmann W, Leaf SL, Leachman SA.

J Behav Med. 2015 Oct;38(5):754-65. doi: 10.1007/s10865-015-9631-8. Epub 2015 Mar 31.

20.

TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.

Ribi S, Baumhoer D, Lee K, Edison, Teo AS, Madan B, Zhang K, Kohlmann WK, Yao F, Lee WH, Hoi Q, Cai S, Woo XY, Tan P, Jundt G, Smida J, Nathrath M, Sung WK, Schiffman JD, Virshup DM, Hillmer AM.

Oncotarget. 2015 Apr 10;6(10):7727-40.

Supplemental Content

Loading ...
Support Center